As of February 2026 Immunomedics has a market cap of A$28.66 Billion. This makes Immunomedics the world's 1179th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.